Trials / Completed
CompletedNCT00607321
Bare Metal Bifurcation Stent Clinical Trial in Humans
The Medtronic Bare Metal Bifurcation Stent Clinical Trial in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the feasibility and safety of the Medtronic Bifurcation Stent System for the treatment of single de novo bifurcation lesions in native coronary arteries with reference vessel diameters (RVD) for the proximal main vessel of 3.8 - 4.3 mm, distal main branch of 3.0 - 3.5 mm, and side branch RVD up to 2.5 mm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic Bifurcation Stent System | Percutaneous Coronary Stenting |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2008-02-05
- Last updated
- 2017-05-18
- Results posted
- 2011-08-31
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT00607321. Inclusion in this directory is not an endorsement.